中国寄生虫学与寄生虫病杂志 ›› 2013, Vol. 31 ›› Issue (2): 3-95-98.

• 论著 • 上一篇    下一篇

弓形虫ESA诱导小鼠产生的CD8+ T细胞对早期黑色素瘤生长的影响

焦玉萌1,方强1 *,夏惠1,王雪梅1,陶志勇1,陈兴智1,沈继龙2   

  1. 1 蚌埠医学院病原生物学教研室、安徽省感染与免疫重点实验室,蚌埠 233030;2 安徽医科大学病原生物学教研室,合肥230032
  • 出版日期:2013-04-30 发布日期:2013-07-02

Role of CD8+ T cells in the Tumor Growth Delay Induced by Toxoplasma gondii Excreted-secreted Antigen in B16F10 Mouse Melanoma Model

JIAO Yu-meng1, FANG Qiang1 *, XIA Hui1, WANG Xue-mei1, TAO Zhi-yong1, CHEN Xing-zhi1, SHEN Ji-long2   

  1. 1 Department of Microbiology and Parasitology, Bengbu Medical College;Anhui Key Laboratory of Infection and Immunity, Bengbu 233030, China;2 Department of Microbiology and Parasitology, Anhui Medical University, Hefei 233032, China
  • Online:2013-04-30 Published:2013-07-02

摘要: 目的  观察弓形虫排泄分泌抗原(TgESA)对B16F10黑色素瘤接种小鼠CD8+ T细胞的影响,以及CD8+ T细胞对B16F10黑色素瘤的作用。 方法  取RH株弓形虫速殖子体外培养12 h后,收集培养液,离心取上清,获得弓形虫ESA。15只C57BL/6小鼠随机分为A、B和C三组(每组5只)。B组和C组每鼠右腋窝皮下接种B16F10黑色素瘤细胞2×105个,A组注射等量无菌PBS。接种后第7天,C组每只小鼠腹腔注射TgESA 100 μl。接种后第13天,处死小鼠,无菌取脾。流式细胞仪检测各组小鼠CD3+CD8+ T细胞所占脾细胞比例;采用免疫磁珠分选B组和C组脾细胞中的CD8+ T细胞,乳酸脱氢酶(LDH)释放法检测两组CD8+ T细胞对B16F10细胞的杀伤作用,分别设效靶细胞比为2.5 ∶ 1、5 ∶ 1和10 ∶ 1。另取30只C57BL/6小鼠随机分为E、F和G三组(每组10只),每鼠接种B16F10细胞2×105个。接种同时,F组和G组小鼠分别尾静脉注射分离自B组和C组的CD8+ T细胞(2×105个/鼠)。观察小鼠瘤体生长情况,记录各组小鼠死亡数和死亡时间,共观察35 d。 结果  流式细胞仪检测结果显示,A、B和C组脾脏CD3+CD8+ T细胞占脾细胞的比例分别为(13.86±0.13)%、(14.18±0.27)%和(15.74±0.28)%,C组显著高于其他两组(P<0.05)。LDH释放试验结果显示,不同效靶细胞比时,C组的CD8+ T细胞杀伤活性均显著高于B组(均P<0.05)。G组的平均出瘤时间[(14.9±1.2)d]晚于F组[(11.9±0.7)d]和E组[(9.4±1.2)d](P<0.05)。3组小鼠自出瘤后瘤体均不断增长,但增长速度无明显差异,G组的瘤体面积始终小于其他两组(均P<0.05)。E、F和G组小鼠分别于B16F10细胞接种后第26、29和30天开始出现死亡,至观察终点(第35天),3组小鼠存活的数量分别为3、5和7只。  结论  TgESA可上调B16F10黑色素瘤小鼠CD8+ T细胞的数量和杀伤功能,上调的CD8+ T细胞具有早期延缓肿瘤生长的作用。

关键词: 刚地弓形虫, 排泄分泌抗原, CD8+ T细胞, 黑色素瘤

Abstract: Objective  To observe the role of CD8+ T cells in the tumor growth delay induced by Toxoplasma gondii excreted-secreted antigens (TgESA) in B16F10 mouse melanoma model in the early stage.  Methods  TgESA were prepared by incubating T. gondii tachyzoites for 12 h in vitro. 15 C57BL/6 mice were randomly assigned to group A, B, and C (5 mice per group). Each mouse in group B and C was subcutaneously injected in right flank with 2×105 B16F10 cells. Mice in group C were intraperitoneally injected with TgESA (100 μl per mouse) at 7 d after B16F10 cells injection. Mice of group A were only injected with PBS. On the 13th day after melanoma cell injection, the mice were sacrified and spleen was removed. The percentage of CD8+ T cells in the spleen was analyzed by flow cytometry. CD8+ T cells were isolated from spleen cells by using immunomagnetic beads. The activity of CD8+ T cells against B16F10 melanoma cells was determined by LDH release assay at different effect-to-target cell ratios (2.5 ∶ 1, 5 ∶ 1, and 10 ∶ 1). Other 30 C57BL/6 mice were randomly divided into group E, F, and G. Each mice were injected with 2×105 B16F10 cells. At the same time, mice in group F and G were simultaneously injected via the tail vein with CD8+ T cells isolated from mice in group B and C. Tumor growth, mortality and survival time of mice were observed and recorded during 35-d observation period.  Results  The percentage of CD3+CD8+ T cells in the spleen cells of group C[(15.74±0.28)%] was significantly higher than that of group B[(14.18±0.27)%] and A [(13.86±0.13)%](P<0.05). At different effect-to-target cell ratios, the activity of CD8+ T cells against B16F10 cells in group C was significantly higher than that of group B (P<0.05). The average time of tumor formation in group G [(14.9±1.2) d] was longer than that in group F [(11.9±0.7) d] and E [(9.4±1.2) d](P<0.05). The tumor size in these groups increased, but there was no obvious difference in the tumor growth rate among the three groups. The tumor size of group G was significantly smaller than the other two groups (P<0.05). In group E, F and G, mice began to die on the 26th day, the 29th day and the 30th day after tumor inoculation, and the number of survival mice was 3, 5 and 7, respectively, at the 35th day after injection.  Conclusions  TgESA may up-regulate the quantity and function of CD8+ T cell in B16F10 melanoma mouse model, which plays a role of delaying tumor growth in early stage.

Key words: Toxoplasma gondii, Excreted-secreted antigens, CD8+ T cell, Melanoma